Category: In Vitro Diagnostics
Global In Vitro Diagnostics
-
Prostate Cancer Diagnostics
... at a CAGR of 13.3% over the analysis period 2024-2030. Preliminary, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$10.0 Billion by the end of the ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical), one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 Billion ... Read More
-
Biosensors
... 7.2% over the analysis period 2024-2030. Non-wearable, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth in ... Read More
-
Cholesterol Testing
... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More
-
Blood Gas and Electrolyte Analyzers
... Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$823.6 Million by ... Read More
-
Immunoassay Systems
... CAGR of 3.6% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$19.4 Billion by the end of the ... Read More
-
Molecular Diagnostics
... CAGR of 9.2% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$16.0 Billion by the end of the ... Read More
-
Nucleic Acid Testing
... at a CAGR of 4.5% over the analysis period 2024-2030. Nucleic Acid Test Kits, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the ... Read More
-
Research ELISA (Enzyme-Linked Immunosorbent Assay)
... Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$478.6 Million ... Read More
-
Companion Diagnostics
... CAGR of 0.3% over the analysis period 2024-2030. Assay kits & Reagents, one of the segments analyzed in the report, is expected to record a -0.4% CAGR and reach US$9.7 Billion by the end of ... Read More
-
High Content Screening (HCS)
... 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$1.0 Billion by the end ... Read More
-
Testing Laboratories
... CAGR of 7.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$30.0 Billion While China is Forecast to Grow at 9.6% CAGR The Testing Laboratories market in the U.S. is estimated at ... Read More
-
Veterinary Rapid Test Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Point-of-Care (POC) Coagulation Testing Devices Global Market Report 2025
... (poc) coagulation testing devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Multi Cancer Early Detection Global Market Report 2025
... early detection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Mycotoxin Testing
... CAGR of 5.9% over the analysis period 2024-2030. Spectroscopy- & Chromatography-Based, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Nucleic Acid Labeling
... at a CAGR of 7.5% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 Billion by the end of the ... Read More
-
Oncology Molecular Diagnostics
... at a CAGR of 11.1% over the analysis period 2024-2030. Breast Cancer, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Bio-MEMS Devices
... CAGR of 16.7% over the analysis period 2024-2030. Bio-MEMS Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million ... Read More
-
Immunofluorescence Assays
... CAGR of 4.4% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.8 Billion by the end of the analysis period. ... Read More
-
Cardiopulmonary Autotransfusion Systems
... at a CAGR of 2.2% over the analysis period 2024-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end ... Read More
-
Enteric Disease Testing
... at a CAGR of 4.8% over the analysis period 2024-2030. Conventional Testing, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
POC Lipid Testing
... at a CAGR of 3.2% over the analysis period 2024-2030. Hyperlipidemia, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$97.0 Million by the end of the ... Read More
Research Assistance
